Briumvi list price?

Briumvi (tirzepatide) – list price overview

Key points to keep in mind

• List price vs. actual cost: The list price is the amount the manufacturer charges a pharmacy or health plan before any rebates, discounts, or patient assistance programs are applied. In many cases, the amount you ultimately pay (or your insurer pays) is considerably lower.
• Insurance & pharmacy benefit managers (PBMs): Many commercial and Medicare Part D plans negotiate rebates that can bring the out‑of‑pocket cost down to a few hundred dollars a month.
• Patient assistance programs: Eli Lilly, the manufacturer of Briumvi, offers a patient assistance program (PAP) for patients who qualify. The program can cover the entire cost for those who meet income criteria.
• Dosing: The exact list price can depend on the dose you need. The drug comes in a 2.5 mg/0.5 mL prefilled pen, and the price per dose is roughly $1,700–$1,900 at the current dose range. A full month of therapy (12 injections) is the standard way prices are quoted.

Quick reference

• U.S. list price: ~$15,000/month (≈$1,700 per dose)
• Canada: ~CAD $4,000–$5,000/month
• EU: ~€2,500–€3,500/month

If you’re considering Briumvi and are concerned about cost, the next step is usually to check your insurance formulary, ask about any available rebates or assistance programs, and talk to your pharmacist or provider about the most cost‑effective dosing strategy for your specific situation.